Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
In the first quarter of this year, our country's innovative drug licensing transactions exceeded $60 billion.
On March 28, the National Medical Products Administration released information showing that in the first quarter of this year, the transaction volume of innovative drugs authorized for external use in China exceeded $60 billion, nearly half of the total for the entire year of 2025. As of March 27, a total of 10 innovative drugs have been approved for market entry in China this year, of which 2 are imported and 8 are domestically produced, marking a historic breakthrough for innovative drugs. (Reporter Dai Xiaohe)
A wealth of information and precise interpretations can be found in the Sina Finance APP.
Editor: Jiang Yuhan